JavaScript Required

This application requires JavaScript to function properly. Please enable JavaScript in your browser settings.

RESEARCH USE ONLY — Not medical advice. Many compounds are experimental/unapproved. Consult a healthcare provider.

Peptide Pro Atlas

Mobile Protocol Planner

Press Ctrl + K to search
›

Interaction Checker

Select peptides to check for potential interactions:

Research Protocol Builder

Subject Information

Units:

Protocol Settings

Enable if you're mid-protocol and want to continue from your current dose.

Per-Peptide Schedule Options

Fine-tune each peptide's dosing schedule. Changes auto-apply to your calendar.

How it works:
  • Ramp-Up: Gradual dose increase to target (disable to start at maintenance)
  • Ramp-Down: Taper off at end of protocol
  • Custom Dosing: Edit exact doses and weeks for each step

Select a peptide above to customize its schedule.

📋 Protocol Templates

▶

Quick-start with pre-configured stacking protocols or save your own.

💡 Tip: Click "+ Add" on multiple templates to combine them. Use "Reset All Peptides" to start fresh.

💉 Reconstitution Calculator

▶

Calculate how many units to draw on your syringe based on vial size, BAC water, and desired dose.

💡 Reconstitution Tips
  • Add BAC water slowly along the vial wall to minimize foaming
  • Clean vial stopper with alcohol swab before piercing
  • Allow vial to reach room temperature before reconstitution
  • Gently swirl (don't shake) to dissolve the peptide
  • Store reconstituted peptides refrigerated (2-8°C / 36-46°F)
  • Most reconstituted peptides are stable for 28-30 days

⏱ Peptide Stacking Timing Guide

▶

Research-based recommendations for introducing and timing peptides in a stack.

📌 Sequential Introduction

  • Start single: Run one peptide for 8-12 weeks to establish baseline before adding a second
  • Assess response: Monitor side effects and efficacy before expanding
  • Beginner rule: Master simple two-peptide combinations before complex stacks

📊 Phased Protocol Design

  • Phase 1 - Acute (1-4 wks): Focus on repair and initial adaptation
  • Phase 2 - Subacute (4-8 wks): Tissue remodeling, add second peptide here
  • Phase 3 - Chronic (8+ wks): Maintenance phase, full stack if tolerated

🌙 GH-Axis Timing

  • Evening pulses: Administer 60-90 minutes before sleep
  • Fasting window: No food 2-3 hours before GH secretagogues
  • Sleep alignment: Align with first slow-wave sleep episode for optimal GH release

🔄 Cycling Recommendations

Peptide Type On Cycle Off Cycle
GH Secretagogues 16 weeks 4 weeks
Ipamorelin 8 weeks 8 weeks
Healing (BPC-157, TB-500) 6-8 weeks 4 weeks min
GLP-1 Agonists Continuous As prescribed

⚠ Critical Rules

  • Never mix peptides in the same syringe
  • BPC-157 + TB-500: Space injections 3-4 days apart when not injecting simultaneously
  • Blood work monitoring recommended before and after protocols
  • Circadian consistency: Same time daily for optimal receptor response

🚫 Current Stack Conflicts

Select peptides in the Protocol Builder to check for conflicts.

Select Peptides

Contraindication Checklist

Check any conditions that apply:

🥗 Dietary Guidance

Optimize your peptide results with targeted nutrition. Recommendations update based on your selected peptides.

Select peptides above to see personalized dietary recommendations.

Saved Protocols

No saved protocols yet.

Configure a protocol above and click "Save Current Protocol".

Peptide Inventory

Data Management

Data is automatically saved to your browser. Export to create a backup file you can store in your directory.

My Profile

Using Imperial units (change in Protocol Builder)

Add Peptide to Inventory

Link to Certificate of Analysis, vendor page, or product info. Used for label QR codes.
Empty 100% Full

Current Inventory

No items in inventory yet.

Add peptides above to start tracking.

Generate Vial Label

Enter URL for COA, vendor page, or product info. Leave blank for no QR code.

Label Preview

QR Code
Peptide Name 10 mg/mL Vendor Name Lot: ABC123 Exp: Jan 2027 Purchased: Jan 2026

Weekly Protocol Calendar

Progress Tracker

📊 Protocol Compliance

0
Doses Completed
0
Total Planned
0%
Compliance Rate
0%

No protocol generated yet.

Generate a protocol in the Protocol Builder to start tracking.

⚖ Weight Tracking

▌
No weight data logged yet

📀 Export Progress

References & Sources

Clinical Trials & Research

  1. [8] Retatrutide Obesity Trial (NEJM 2023):
    https://pubmed.ncbi.nlm.nih.gov/37366315/
  2. [9] Retatrutide T2D Trial:
    https://pubmed.ncbi.nlm.nih.gov/37385280/
  3. [10] Lilly Press Release (Retatrutide Arms):
    https://investor.lilly.com/news-releases/news-release-details/lillys-phase-2-retatrutide-results-published-new-england-journal
  4. [11] Survodutide Trial:
    https://pubmed.ncbi.nlm.nih.gov/38847460/

Interactions & Safety

  1. [12] Melatonin Interactions (Mayo Clinic):
    https://www.mayoclinic.org/drugs-supplements-melatonin/art-20363071

Peptide Reviews (Preclinical/Experimental)

  1. [13] BPC-157 Review:
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8504390/
  2. [14] Thymosin Beta-4 Review:
    https://pubmed.ncbi.nlm.nih.gov/27662631/
  3. [15] GHK-Cu Review:
    https://pubmed.ncbi.nlm.nih.gov/26004703/
  4. [16] Semax Review:
    https://pubmed.ncbi.nlm.nih.gov/24403844/
  5. [17] Selank Review:
    https://pubmed.ncbi.nlm.nih.gov/31625062/

Vendor-Derived Protocols (Non-Clinical)

  1. [18] MOTS-c Vendor Dosing (PeptideDoser):
    https://www.peptidedoser.com/peptide-dosing/mots-c-5mg.html
  2. [19] MOTS-c Vendor Dosing (ResearchDosing):
    https://researchdosing.com/mots-c/

Nutrition, Exercise & Supplement Research

  1. [20] Strategies for Minimizing Muscle Loss During Incretin-Mimetic Drugs (PMC 2024):
    https://pmc.ncbi.nlm.nih.gov/articles/PMC11611443/
  2. [21] Protein Intake and Muscle Preservation (Endocrine Society 2025):
    https://www.endocrine.org/news-and-advocacy/news-room/endo-annual-meeting/endo-2025-press-releases/haines-press-release
  3. [22] Preservation of Lean Soft Tissue During GLP-1 Weight Loss (PMC 2025):
    https://pmc.ncbi.nlm.nih.gov/articles/PMC12536186/
  4. [23] Exercise Regimens to Optimize GLP-1 Therapy (Good Hearts Health 2025):
    https://www.goodheartshealth.com/2025/01/28/exercise-regimens-to-optimize-glp1-therapy-tirzepatide-semaglutide/
  5. [24] Dietary Supplement Considerations During GLP-1RA Treatment (PMC 2025):
    https://pmc.ncbi.nlm.nih.gov/articles/PMC12685510/
  6. [25] Nutritional Approaches to Enhance GLP-1 Analogue Therapy (MDPI 2024):
    https://www.mdpi.com/2673-4168/5/4/88
  7. [26] Nutritional Priorities to Support GLP-1 Therapy - Joint Advisory (2025):
    https://www.sciencedirect.com/science/article/pii/S0002916525002400

Growth Hormone Secretagogues Research

  1. [27] GHRH and GHRP Synergy - Growth Hormone Secretagogues Review (Endocrine Reviews):
    https://academic.oup.com/edrv/article/29/5/560/2354986
  2. [28] MK-677 (Ibutamoren) - Effects on GH and IGF-1 (J Clin Endocrinol Metab):
    https://academic.oup.com/jcem/article/83/2/320/2865101
  3. [29] IGF-1 Physiology and Clinical Applications (Endocrine Reviews):
    https://academic.oup.com/edrv/article/30/5/494/2355065
  4. [30] Myostatin Inhibition for Muscle Growth - ACE-031 and Follistatin (Molecular Therapy):
    https://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(15)00032-8

Mitochondrial & Longevity Peptides

  1. [31] Mitochondrial-Derived Peptides: MOTS-c, Humanin, and SHLPs (Cell Metabolism):
    https://www.cell.com/cell-metabolism/fulltext/S1550-4131(18)30126-6

Cognitive & Neuroprotective Peptides

  1. [32] Dihexa - Angiotensin IV Analog for Cognitive Enhancement (J Pharmacol Exp Ther):
    https://jpet.aspetjournals.org/content/347/3/766

Immune & Inflammatory Peptides

  1. [33] VIP (Vasoactive Intestinal Peptide) - Immunomodulation and CIRS (Frontiers Immunology):
    https://www.frontiersin.org/articles/10.3389/fimmu.2020.01168/full

Reproductive & Hormonal Peptides

  1. [34] Kisspeptin in Reproductive Endocrinology (Endocrine Reviews):
    https://academic.oup.com/edrv/article/38/5/470/4085485

Metabolic & Weight Loss Compounds

  1. [35] Tesofensine for Obesity - Phase II Clinical Trials (The Lancet):
    https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(08)61525-1/fulltext
  2. [36] Larazotide Acetate for Celiac Disease - Intestinal Permeability (Gastroenterology):
    https://www.gastrojournal.org/article/S0016-5085(12)00882-7/fulltext
  3. [37] Dual and Triple Agonists in Obesity - Pemvidutide, Survodutide, Retatrutide (Nature Reviews Drug Discovery):
    https://www.nature.com/articles/s41573-023-00870-0

General Peptide Research Resources

  1. [38] Sermorelin - GHRH 1-29 Clinical Use (J Clin Endocrinol Metab):
    https://academic.oup.com/jcem/article/82/5/1412/2823304
  2. [39] ARA-290 - Non-Erythropoietic Tissue Protective Peptide (Mol Med):
    https://molmed.biomedcentral.com/articles/10.1186/1476-9255-7-16
  3. [40] Humanin - Mitochondrial Peptide Cytoprotection (Aging Cell):
    https://onlinelibrary.wiley.com/doi/full/10.1111/acel.12799
  4. [41] Peptide Bioavailability and Delivery Routes (Pharmaceutics):
    https://www.mdpi.com/1999-4923/12/11/1076
  5. [42] Peptide Stability and Storage Guidelines (Eur J Pharm Biopharm):
    https://www.sciencedirect.com/science/article/pii/S0939641115000831

📋 Changelog & Version History

Track all updates and improvements to Peptide Pro Atlas.

Version 2.3

February 6, 2026

🔥 New Features

  • Reconstitution Calculator: New tool to calculate exactly how many units to draw on your syringe. Enter vial size, BAC water volume, and desired dose - get instant results with a visual syringe preview. Supports mg, mcg, and IU units with U-100, U-50, and U-30 syringe types. Includes reconstitution tips and warnings for doses exceeding syringe capacity.
  • Traditional Calendar View: New monthly grid layout option for the calendar. Toggle between List View and Calendar View to see your protocol in a familiar day/date format with color-coded doses by phase. Today's date is highlighted automatically.
  • Imperial/Metric Unit System: New toggle to switch between Imperial (ft/in, lbs) and Metric (cm, kg) units for height and weight. Selection automatically syncs between Protocol Builder and Profile sections, and persists across sessions.
  • Dark Mode Toggle Improved: Theme toggle button now displays "Dark Mode" or "Light Mode" text instead of icons for clearer indication of current state.
  • Retatrutide + MOTS-c Metabolic Template: New 24-week protocol template combining conservative Retatrutide (0.5mg starting, +0.5mg every 4 weeks to 4mg) with MOTS-c 2.5mg EOD for comprehensive metabolic optimization.
  • Inventory Label Generator: Generate and print labels for your inventory items. Each label includes peptide name, concentration, vendor, lot number, and expiration date. Choose from small/medium/large label sizes, toggle which fields to include, download as PNG, or print multiple labels at once. Label preferences are saved and included in data exports.
  • Product URL in Inventory: Each inventory item can now store a product URL (Certificate of Analysis, vendor page, product info). This URL is used for label QR codes and is automatically populated when generating labels for that item.
  • Purchase Date on Labels: New checkbox option to include the purchase date on printed labels. Toggle on/off like other label fields (lot #, expiration, vendor).

🔧 UI Improvements

  • Comprehensive Dark Mode Overhaul: 140+ dark mode CSS rules ensure proper contrast across all UI elements including buttons, inputs, cards, modals, calendar views, dose logs, inventory items, warning boxes, phase indicators, template cards, and more. All interactive elements now have proper backgrounds and text colors in dark mode.
  • Button Contrast Fix: All button types (primary, success, warning, default) now have proper backgrounds and readable text in dark mode. Calendar view toggles, unit toggles, and undo/redo buttons all properly styled.
  • Mobile Template Visibility: Fixed issue where protocol templates near the bottom of the list were cut off on mobile devices. Increased scroll area and padding.
  • BMI Display: Label updated to "Current BMI" for clarity.
  • Streamlined Interface: Removed Dashboard tab for a cleaner, more focused experience. Protocol Builder is now the default landing tab.
  • Collapsible Section Indicators: All collapsible sections now have flashing status indicators - red when collapsed (click to expand) and green when expanded (section is open). Provides clear visual feedback on section state.

🐛 Bug Fixes

  • Unit Conversion Sync: Height and weight values now properly convert and sync between imperial and metric fields in real-time.
  • Calendar View Persistence: Selected calendar view (List/Traditional) is maintained when regenerating protocols or changing display units.
  • Syringe Preview Alignment: Fixed visual scaling issue where the fill indicator did not align with tick marks. Fill now correctly matches unit positions on all syringe types.
  • BAC Water Smart Increment: Arrow keys and spinner now increment by the smallest decimal place in the current value (e.g., 1.5 increments by 0.1, whole numbers increment by 1).
  • Epithalon Protocol Fixed: Corrected from continuous daily dosing to proper cycle-based protocol (10 or 20-day cycles, 2-3x per year). Added configuration panel with 4 protocol options and appropriate warnings about cycle timing.

Version 2.2

January 30, 2026

🔥 New Features

  • Stack Conflict Checker: Dynamic section in Stacking Timing Guide that shows which peptides in your current stack should NOT be used together, with severity levels and explanations. Auto-expands when conflicts detected and shows conflict count badge in title.
  • Multi-Template Stacking: Templates now ADD to current selections instead of replacing. Combine multiple templates to build complex stacks!
  • Reset All Peptides: New button to quickly clear all peptide selections and start fresh.
  • Improved Template Cards: Consistent layout with buttons at bottom. Cards show green border when applied, peptide tags highlight in green, and button changes to red "Remove" to easily undo.
  • Exercise & Fitness Guidance: Dynamic exercise recommendations now appear alongside dietary guidance when peptides are selected. Each category has tailored fitness advice (resistance training for GLP-1s, Zone 2 cardio for mitochondrial, active recovery for healing peptides, etc.)

🐛 Bug Fixes

  • MOTS-c EOD Calendar Fix: Fixed timezone-related date calculation issues that could cause incorrect day display on calendars. All date handling now uses local timezone consistently.
  • Improved Date Helpers: Added formatLocalDate() and calcWeek() helper functions for consistent date calculations across all protocols.

📚 Peptide Stacking Timing Research

  • Sequential Introduction: Start with a single peptide (8-12 weeks) to establish baseline before adding second peptide.
  • Phased Approach: Separate acute (repair), subacute (remodeling), and chronic (maintenance) phases. Add variables sequentially.
  • GH-Axis Timing: Administer 60-90 minutes before sleep to coincide with natural GH release during slow-wave sleep.
  • Cycling Recommendations: GH peptides typically 16 weeks on / 4 weeks off; Ipamorelin 8 weeks on / 8 weeks off to prevent receptor desensitization.
  • Stacking Interval: When combining BPC-157 + TB-500, space injections 3-4 days apart; never mix peptides in the same syringe.
  • Advanced Stacks: 6-8 week duration followed by 4 weeks minimum break; blood work monitoring recommended.

Version 2.1

January 30, 2026

🔥 New Features

  • Category-Organized Peptide Lists: Both Interaction Checker and Protocol Builder now group peptides by category (Weight Loss first), with collapsible sections and "Select All" buttons for each category.
  • Dietary Guidance System: Dynamic dietary recommendations that update based on selected peptides, with category-specific nutrition advice (protein requirements, fasting windows, supplements).
  • Changelog Tab: Version history tracking for all application updates.

💊 New Protocols

  • Retatrutide Conservative to 4mg: Start at 0.5mg, increase by 0.5mg every 4 weeks until reaching 4mg maintenance (32 weeks ramp-up).
  • Retatrutide Conservative to 6mg: Same conservative pattern extending to 6mg maintenance (48 weeks ramp-up).
  • MOTS-c Low Dose EOD: 2.5mg every other day protocol option.

🔧 Improvements

  • Interaction Checker Auto-Scroll: Clicking "Use Protocol Selections" now automatically scrolls to show interaction results.
  • Protocol Loading: Fixed dietary guidance and contraindication updates when loading saved protocols or applying templates.
  • Clean Print Protocol: New focused print output showing only relevant data - peptide summary, weekly schedule, warnings, and dietary notes. No more cluttered prints!

📋 New Protocol Templates (10 Added)

  • Triple Agonist Protocol: Retatrutide - most powerful weight loss option
  • GH Optimization Stack: CJC-1295 + Ipamorelin synergy
  • Comprehensive Healing: BPC-157 + TB-500 + GHK-Cu
  • Gut Healing Protocol: BPC-157 + KPV for GI issues
  • Immune Support: Thymosin Alpha-1
  • Sleep Optimization: DSIP + Melatonin
  • Skin Rejuvenation: GHK-Cu + BPC-157
  • Weight Loss + Muscle Sparing: Tirzepatide + CJC-1295 + Ipamorelin
  • Performance & Recovery: BPC-157 + TB-500 + Ipamorelin
  • Deep Cognitive Enhancement: Semax + Selank + Dihexa

Version 2.0

January 29, 2026

🔥 Major Updates

  • MOTS-c Dosing Corrected: Updated from incorrect daily dosing to research-validated 5-10mg 2-3x/week protocol.
  • SS-31 Mitochondrial Priming: Added recommendation to run SS-31 for 2-4 weeks BEFORE MOTS-c for optimal mitochondrial priming.
  • Epithalon Dosing Corrected: Fixed from 10-50mg/day to evidence-based 5-10mg/day.
  • Longevity Stack Optimized: Resequenced to put SS-31 first (weeks 1-4), then MOTS-c (weeks 5+).

💊 New Peptides Added

  • Sermorelin, GHRP-2, GHRP-6, Hexarelin, MK-677 (Ibutamoren)
  • CJC-1295 with DAC, IGF-1 LR3, MGF, PEG-MGF
  • Follistatin 344, ACE-031, Humanin
  • Dihexa, P21, Cortexin, VIP
  • Kisspeptin, Gonadorelin, Tesofensine
  • Larazotide, Thymosin Beta-10, ARA-290

🔧 Protocol Templates

  • Mitochondrial Priming Protocol: SS-31 (weeks 1-4) → MOTS-c (weeks 5+)
  • Longevity Stack (Optimized): Corrected sequencing with SS-31 priming
  • Retatrutide "Slow and Steady": 0.5mg start, +0.5mg every 2 weeks

📚 New Interactions & Warnings

  • MOTS-c + GLP-1 synergy documentation
  • MOTS-c protocol notes (cycling, NAD+ supplementation)
  • GH Secretagogue synergy and stacking guidance
  • Myostatin inhibitor safety warnings
  • Tesofensine contraindications

Version 1.5

January 28, 2026

🔥 New Features

  • Progress Tracker: Log doses, track adherence, and monitor your peptide journey with charts and statistics.
  • Protocol Templates: Pre-configured stacking protocols with one-click apply.
  • Undo/Redo System: Full history tracking for protocol changes with keyboard shortcuts (Ctrl+Z/Y).
  • Mobile Tab Scroll Indicators: Visual arrows showing scrollable tabs on mobile devices.

🔧 UI Improvements

  • Tab reordering: Protocol → Calendar → Inventory
  • Collapsible sections for cleaner interface
  • Per-peptide schedule customization
  • Enhanced calendar export with ICS support

Version 1.0

January 2026

🎉 Initial Release

  • Peptide Library: Comprehensive database with dosing, protocols, and evidence levels.
  • Interaction Checker: Drug interaction and contraindication warnings.
  • Protocol Builder: Custom protocol creation with ramp-up/down phases.
  • Calendar Generator: Visual calendar with printable schedules.
  • Inventory Management: Track peptide stock, expiration, and storage.
  • Source Citations: FDA labels, clinical trials, and research references.
⚠

IMPORTANT LEGAL DISCLAIMER

FOR RESEARCH AND EDUCATIONAL PURPOSES ONLY

The information provided in this application, including but not limited to peptide protocols, dosing schedules, interactions, and recommendations, is intended solely for informational, educational, and research purposes. This application and its contents DO NOT constitute medical advice, diagnosis, treatment, or any form of healthcare recommendation.

NO MEDICAL ADVICE: Nothing contained herein should be construed as the practice of medicine, nursing, or any other healthcare profession. Users should not rely on this information as a substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or treatment options.

ASSUMPTION OF RISK: Any use of the information provided herein is at the user's sole risk. The creators, developers, contributors, and distributors of this application expressly disclaim any and all liability for any direct, indirect, incidental, consequential, special, or exemplary damages arising out of or in connection with the use of, or inability to use, this application or any information provided herein, including but not limited to damages for loss of profits, goodwill, use, data, or other intangible losses.

NO WARRANTY: This application and its contents are provided "AS IS" without warranty of any kind, express or implied, including but not limited to the warranties of merchantability, fitness for a particular purpose, accuracy, completeness, or non-infringement.

INVESTIGATIONAL SUBSTANCES: Many peptides referenced herein are investigational, experimental, or NOT APPROVED by regulatory agencies (including but not limited to the U.S. Food and Drug Administration) for human use. Their safety and efficacy have not been established through adequate and well-controlled clinical trials.

INDEMNIFICATION: Users agree to indemnify, defend, and hold harmless the creators, developers, contributors, and distributors of this application from and against any and all claims, damages, obligations, losses, liabilities, costs, or debt, and expenses arising from the use of this application or reliance on any information contained herein.

JURISDICTION: This disclaimer shall be governed by and construed in accordance with applicable law. If any provision of this disclaimer is held to be invalid or unenforceable, the remaining provisions shall continue in full force and effect.

ACKNOWLEDGMENT: By using this application, you acknowledge that you have read, understood, and agree to be bound by this disclaimer. If you do not agree with any part of this disclaimer, you must not use this application.

🧬

Welcome to Peptide Pro Atlas

Your comprehensive tool for building, tracking, and managing peptide research protocols.

📊 Dashboard Overview
🧪 Protocol Builder
📅 Calendar View
📚 Peptide Library
⚠ Interaction Checker
📈 Progress Tracking
🔍 ESC
Quick Actions
🧪 Go to Protocol Builder Build
📅 Go to Calendar Schedule
📚 Go to Library Browse
Peptides